Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S (2020) Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and Cardiovascular Diseases
Nella gestione del sovrappeso, molti studi sottolineano l'assenza di riduzioni rilevanti della massa grassa con la supplementazione
Ralph DeFronzo, a diabetes expert and researcher at the University of Texas Health Science Center in San Antonio, advised that these two medication classes be considered first when treating type 2 diabetes because they help preserve beta-cell function
One of the good side effects is that it has given all my bloodwork from the lab to be normal
"Here in Indiana, 71% of adults are living with obesity or overweight," he said